Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Parentheticals (Details)

v2.4.1.9
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Parentheticals (Details) (USD $)
 3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Deferred Financing Costs {1}    
Amortization of deferred financing costs related to convertible debt $ 0fil_AmortizationOfDeferredFinancingCostsRelatedToConvertibleDebt $ 4,835fil_AmortizationOfDeferredFinancingCostsRelatedToConvertibleDebt
Research and Development    
Clinical Studies expenses - fees, charges and related expenses 209,000fil_ClinicalStudiesExpensesFeesChargesAndRelatedExpenses 391,000fil_ClinicalStudiesExpensesFeesChargesAndRelatedExpenses
Stock Based Compensation    
Compensation expenses recorded 4,991fil_CompensationExpensesRecorded 22,372fil_CompensationExpensesRecorded
Common shares from convertible debentures and related accrued interest 52,496,746fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest 32,742,611fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest
common shares from outstanding warrants 8,512,393fil_CommonSharesFromOutstandingWarrants 15,350,539fil_CommonSharesFromOutstandingWarrants
Advertising / Public Relations Costs    
Advertising and Public Relations costs are charged to operations when incurred 60,030fil_AdvertisingAndPublicRelationsCostsAreChargedToOperationsWhenIncurred 12,853fil_AdvertisingAndPublicRelationsCostsAreChargedToOperationsWhenIncurred
Concentrations of Credit Risk    
Company maintains cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation ("FDIC") limit. $ 250,000fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1 $ 0fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1